Comparison

DIMS vs EMDEX Reference

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

DIMS

This offline drug index provides comprehensive information on medications available in Bangladesh. It allows users to search drugs by brand, generic name, or condition, and offers detailed data on indications, dosage, side effects, and pricing. The app also includes information on medical events and allows users to bookmark favorite drugs.

Highlights
  • Offline drug index for Bangladesh
  • Search drugs by brand, generic, or condition
  • Detailed drug information (indications, dosage, side effects)
  • Drug synchronization by strength, form, price
  • Bookmark favorite drugs
  • Information on international medical events
Features
Read full description

Title: DIMS Short description: DIMS is the Best offline mobile drug index of Bangladesh. Full description: Key Features & Benefits 1. Drugs details (Indications, Dosage & administrations, Contraindications, Side effects, Precautions & warnings, FDA pregnancy category, Therapeutic class, Pack size & price). 2. Search Drugs (Search by Brand name, Generic name or Condition). 3. Drugs by Brands ( A-Z brands). 4. Drugs by Generic ( A-Z generic). 5. Drugs by Classes. 6. Drug by Condition. 7. Favourite Drugs (Bookmark brand name). 8. Medical events (information of international medical events). On the drug name the drugs are synchronized by strength, forms, generic name, price & company name. Also we use specific forms icon for easy recognition. The app also provides thorough information about particular drugs such as: indications, dosage& administrations, contraindications, side effects, precautions & warnings, FDA pregnancy category, pack size &price. DIMS (Drug Information Management System) is the premier mobile drug index apps of Bangladesh. It is owned and operated by "TWgBD (Telemedicine working group of Bangladesh)". DIMS is the most comprehensive, advanced and up-to-date information source on available and recent drug products to serve the healthcare & pharmaceutical professionals in the country. Disclaimers DIMS is an mobile drug index apps, to be used only as a reference aid and educational purpose and is not intended for medical advice, diagnosis or treatment; neither intended to be a substitute for the exercise of professional judgment and should not be relied upon solely for final treatment decisions. The clinical information contained in the information is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. We used reliable & authentic data sources and company literatures. Although great effort has been made in compiling and checking the information contained in this apps to ensure that it is accurate, the publisher, the authors, editors and their servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions or inaccuracies in this website whether arising from negligence or otherwise howsoever, or for any consequences arising there from. A LICENSED MEDICAL PROFESSIONAL IS RESPONSIBLE FOR INDEPENDENTLY REACHING ANY MEDICAL JUDGMENT, AND FOR ANY RESULTING DIAGNOSIS AND TREATMENTS, NOTWITHSTANDING ANY USE OF THE CONTENT BY SUCH MEDICAL PROFESSIONAL. BY USE OF THIS APPS YOU ACKNOWLEDGE AND AGREE THAT THE INFORMATION ON THIS APPS MAY CONTAIN INACCURACIES AND OTHER ERRORS.

About

EMDEX Reference

This app provides comprehensive drug and therapeutic information for Nigeria, including essential medicines, treatment guidelines, and drug product details. It features an interaction checker, diagnosis and management of prevalent diseases, and a natural health products compendium. Designed for healthcare professionals, it offers enhanced search and detailed drug information.

Highlights
  • Comprehensive drug product database
  • Essential Medicines List
  • Standard Treatment Guideline recommendations
  • Interaction checker
  • Natural health products compendium
  • Diagnosis and management of prevalent diseases
  • Rapid drug news and safety alerts
Features
Read full description

EMDEX (Essential Medicines Index) is Nigeria’s trusted source for drug and therapeutic information published since 1991. Based on both the WHO Model Formulary and Nigeria’s Essential Medicines Lists, EMDEX is unique to Nigeria as it also details over 15000 drug products approved for use in the country. EMDEX App has several unique functionalities, practice resources & tools including: 1. Nigeria's most comprehensive & regularly updated Drug Product Database 2. Nigeria's Essential Medicines List (EML & EMLc) 3. NSTG (Nigeria's Standard Treatment Guideline) Recommendations under the drug details 4. Dental Formulary 5. Therapeutic Notes 6. Compendium of Natural Health Products 7. Diagnosis & Management of Prevalent Diseases in the country 8. Interaction Checker 9. RapidRx – Keep up-to-date with latest drug news, safety alerts & recalls. 10. Indication Index, etc. EMDEX is for healthcare professionals only. Other key features: - Enhanced Search Functionality (Search by Brand, Generic or Indication). - Easy to navigate by Generics, Therapeutic Classes, Indications. - Drugs details featuring Adult & Child Dosages, Renal Dose, Administration, Pharmacovigilance, Advice to Patients, Nursing Action, Drug Use in Pregnancy & Lactation, Drug product descriptions & Pack sizes, etc. - Favourite Drugs (Build your Formulary by Bookmarking your favourite drugs) - Feedback (You can directly post your valuable suggestions, advice & comments) Disclaimers EMDEX Mobile Drug Reference & Therapeutic Notes is to be used only as a reference aid and educational purpose and is not intended for medical advice, diagnosis or treatment. It is neither intended to be a substitute for the exercise of professional judgment and should not be relied upon solely for final treatment decisions. The clinical information contained in the App is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. We used reliable & authentic data sources and company literatures. Although great effort has been made in compiling and checking the information contained in this app to ensure that it is accurate, the publisher, the authors, editors and their servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions or inaccuracies in this app whether arising from negligence or otherwise howsoever, or for any consequences arising there from. A LICENSED MEDICAL PROFESSIONAL IS RESPONSIBLE FOR INDEPENDENTLY REACHING ANY MEDICAL JUDGMENT, AND FOR ANY RESULTING DIAGNOSIS AND TREATMENTS, NOTWITHSTANDING ANY USE OF THE CONTENT BY SUCH MEDICAL PROFESSIONAL. BY USE OF THIS APP YOU ACKNOWLEDGE AND AGREE THAT THE INFORMATION ON THIS APP MAY CONTAIN INACCURACIES AND OTHER ERRORS. Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

Screenshots

DIMS3 screens
EMDEX Reference4 screens

Verdict

The call

The clearest difference is rating: EMDEX Reference at 4.7 against DIMS's 3.7. DIMS's advantage is in-app purchases (none vs 3) and ads (none vs shown). On price, review sentiment, update cadence and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. EMDEX Reference sells 3 in-app purchases, starting at $0.99 per 7 days. DIMS asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

EMDEX Reference holds the better App Store score, 4.7 against 3.7. That said, the two scores are not equally well evidenced: DIMS has 613 ratings behind it against 3, so its average is the more settled of the two. Written reviews point the same way: 43% of DIMS's written reviews are positive against 50% of EMDEX Reference's.

UpkeepUpdate frequency

DIMS ships an update every 3 months, EMDEX Reference every 5 months. The most recent releases landed on September 25, 2026 and September 10, 2026 respectively.

Scorecard6 real differences · 4 level
DIMS versus EMDEX Reference: the parameters behind the verdict, then further details
ParameterDIMSEMDEX Reference
PriceFreeFree
Rating3.7 (613 ratings)4.7 (3 ratings) — better
Positive reviews43.1% of reviews50.0% of reviews — better
Number of ratings613 — better3
Update frequencyEvery 3 months — betterEvery 5 months
AdsNo — betterYes
In-app purchasesNo — betterYes
MonetizationFree — betterAd-supported
DevicesiPhone, iPodiPhone, iPad, iPod — better
Requires iOS12.0 — better15.6
Further details — not scored
Size50 MB53 MB
Age rating17+17+
DeveloperITmedicusEMDEX Limited

Customer experience

DIMS

All ratings613 ratings
Positive63.9%
Neutral11.9%
Negative24.1%
Written reviews195 reviews
Positive43.1%
Neutral14.9%
Negative42.1%

EMDEX Reference

All ratings3 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews2 reviews
Positive50.0%
Neutral0.0%
Negative50.0%

In-app purchases

None

DIMS

No in-app purchases

3 purchases

EMDEX Reference

Subscriptions3
  • Weekly Plan$0.997 Days
  • Querterly Plan$6.993 Months
  • Yearly Plan$24.991 Year

Questions

Is DIMS free?
DIMS is free to download, with no in-app purchases.
Is EMDEX Reference free?
EMDEX Reference is free to download, with in-app purchases available.
Which has better reviews, DIMS or EMDEX Reference?
EMDEX Reference is rated higher. DIMS averages 3.7 out of 5 from 613 ratings, while EMDEX Reference averages 4.7 from 3 ratings.
Do DIMS or EMDEX Reference have ads?
EMDEX Reference shows ads; DIMS does not.
Which is updated more often, DIMS or EMDEX Reference?
DIMS ships an update every 3 months, and EMDEX Reference every 5 months. Most recently, DIMS was updated on September 25, 2026 and EMDEX Reference on September 10, 2026.

Other comparisons